Table 1.
Histological scoring of granulomas in CVID, sarcoidosis, PS and TB
| Histology hallmark | CVID | Sarcoidosis | PS | TB |
|---|---|---|---|---|
| Original tissue structure affected | 2.5 (2–3) | 2.5 (2–3) | 2 (1–3) | 2 (2–3) |
| Presence of micro granulomas | 3***/**/** (2–3) | 1 (1–1) | 1 (0–2) | 0.5 (0–1) |
| Presence of large granulomas | 1****/***/** (0–1) | 3 (2–3) | 3 (2–3) | 3 (2–3) |
| Clustered granulomas | 3 (3–3) | 3 (2–3) | 2.5 (0–3) | 2 (1–3) |
| Solitary granulomas | 1* (0–1) | 1.5 (1–3) | 2.5 (1–3) | 2 (2–3) |
| Well-circumscribed granulomas | 1** (0–2) | 3 (2–3) | 2 (2–3) | 2 (2–3) |
| Confluent granuloma areas | 3* (2–3) | 2 (1–3) | 1 (0–3) | 1.5 (1–3) |
| Multinucleated giant cells present | 0.5 (0–1) | 1.5 (1–3) | 1 (1–3) | 2 (1–3) |
| Foreign body giant cells | 0 (0–0) | 0.5 (0–3) | 1.5 (0–3) | 1 (0–1) |
| Touton giant cells | 0 (0–1) | 1 (0–2) | 1 (0–2) | 1 (0–2) |
| Langhans giant cells | 0.5* (0–3) | 3 (1–3) | 1.5* (1–3) | 3*/* (3–3) |
| Asteroid body giant cells | 0 (0–0) | 0 (0–1) | 0 (0–3) | 0 (0–0) |
| Lymphocyte infiltration in granuloma | 2 (1–2) | 1.5 (1–2) | 1.5 (1–2) | 1 (1–2) |
| Fibrosis in center of granuloma | 0 (0–1) | 1** (1–3) | 0 (0–1) | 1 (1–3) |
| Fibrosis in adjacent surrounding tissue | 0.5** (0–2) | 2.5 (1–3) | 1 (0–3) | 3 (2–3) |
| Necrotic areas inside granulomas | 0 (0–0) | 0.5 (0–1) | 0 (0–0) | 1.5 (0–3) |
CVID = Common Variable Immunodeficiency; PS = pseudo sarcoidosis; TB = tuberculosis. Numerical scoring: 0 = not present, 1 = limitedly present, 2 = frequently present, 3 = present throughout slide. A 2way anova, with multiple comparisons test correction using Tukey’s test, comparing the mean of each disease group per histology hallmark was performed; * = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤ 0.001, **** = P ≤ 0.0001